RxDoctor Payments Data
★ My doctorsLook up a doctor →

Miguelangelo Perez Cruet, MD

Neurosurgery · Royal Oak, MINPI 1841287463

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $36,665 of the $57,481 with a category attached, or 63.8%. Orthofix Medical, Inc. accounts for 80.0% of it on its own, with 35 other manufacturers making up the rest. Reporting peaked in 2021 at $20,504 and has fallen 93.1% since, to $1,423 in 2025.

$57,481in general payments, 2019–2025

Across 214 payments — averaging $268.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Orthofix Medical, Inc.$46K
  • Cerapedics Inc.$3K
  • Medtronic$2K
  • Kuros Biosciences USA, Inc$1K
  • Innovasis Inc$781
  • Stryker$727
  • plus $5K from 30 others
$161,341in research payments, 2019–2025

Across 4 payments — averaging $40,335 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Orthofix Medical, Inc.$161K

What the payments were for

  • Consulting fees$36,66564%
  • Travel & lodging$9,21216%
  • Food & beverage$11,41520%
  • Education$1390%
  • Entertainment$510%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Orthofix Medical, Inc.54$45,996
Cerapedics Inc.12$2,612
Medtronic(2 entities)57$1,563
Kuros Biosciences USA, Inc8$1,086
Innovasis Inc8$781
Stryker6$727
Augmedics Inc.10$505
Spineology Inc.3$482
Arteriocyte Medical Systems, Inc.2$334
Si-bone, Inc.4$304
Aesculap, Inc.6$301
Spinal Elements, Inc.5$291
Globus Medical(2 entities)4$267
Boston Scientific3$255
Nextremity Solutions Inc.1$245
Pinnacle, Inc2$184
Intrinsic Therapeutics1$155
Surgical Theater. Inc.1$136
Johnson & Johnson1$135
Livanova USA, Inc.1$135
Aesculap Implant Systems, LLC1$125
Integrity Implants Inc.1$123
Amplify Surgical, Inc.1$106
Integra Lifesciences Corporation1$91
Longeviti Neuro Solutions Inc1$70
AbbVie3$65
Spine Wave, Inc.3$62
Surgalign Spine Technologies, Inc.1$58
Merz Pharmaceuticals, LLC2$58
Pacira Pharmaceuticals Incorporated2$49
Providence Medical Technology, Inc.3$46
Baxter Healthcare1$39
UCB, Inc.2$37
Scilex Pharmaceuticals Inc.1$22
Elevation Spine, Inc.1$22
Zimmer Biomet1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few neurosurgery providers in Michiganto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$223,952
Medicare patients
170
Services billed
749

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban23$7,714
Montelukast Sodium23$178
Methylprednisolone12$73

Paid to pharmacies, not to this prescriber.

Other neurosurgery in Royal Oak

See the full list for Michigan →

Where these figures come from

Is this you, or does something look wrong? →